Volume 38, Issue 6, Pages 748-756 (December 2014) Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China) Beatriz Serrano, Laia Alemany, Patricia Alonso de Ruiz, Sara Tous, Marcus Aurelho Lima, Laia Bruni, Asha Jain, Gary M. Clifford, You Lin Qiao, Thomas Weiss, F Xavier Bosch, Silvia de Sanjosé Cancer Epidemiology Volume 38, Issue 6, Pages 748-756 (December 2014) DOI: 10.1016/j.canep.2014.09.003 Copyright © 2014 The Authors Terms and Conditions
Fig. 1 Cervical cancer burden and sociodemographic indicators in Brazil, Mexico, India and China compared to the world. CCI: Cervical Cancer Incidence; CCM: Cervical Cancer Mortality; ASR: Age Standardized Rate (per 100 000 women); GDP (PPP): Gross Domestic Product per capita; *Ranking of cervical cancer incidence to other cancers among all women. Ranking is based on crude incidence rates. Ranking using ASR may differ. References: [1]; [5]; [22]. Cancer Epidemiology 2014 38, 748-756DOI: (10.1016/j.canep.2014.09.003) Copyright © 2014 The Authors Terms and Conditions
Fig. 2 Contribution of HPVs 16/18/31/33/45/52/58 in cases of invasive cervical cancer that tested positive for HPV DNA, in Brazil, Mexico, India and China compared to the worldwide HPV type distribution. Additional information: Available data are from unvaccinated women (pre-vaccination period). Type specific estimations: Numerator=single infections+proportional attribution of multiple types; Denominator=HPV/DNA positive cervical cancer cases for any type (for more details, please see methodological section from [8]). Cancer Epidemiology 2014 38, 748-756DOI: (10.1016/j.canep.2014.09.003) Copyright © 2014 The Authors Terms and Conditions